ClinicalTrials.gg
Drug

Fremanezumab clinical trials

Also written TEV-48125 and Ajovy.

studies test it
29
open now
2
in phase 3
14
first study started
2013

How each study uses fremanezumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the fremanezumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Sept 2018 · AJOVY · BLA 761089 (FDA, Drugs@FDA)
European Union
28 Mar 2019 · Ajovy · EMEA/H/C/004833 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Fremanezumab
21
fremanezumab-vfrm
2
LBR-101 High Dose
2
LBR-101 Low Dose
2
TEV-48125, anti-calcitonin gene-related peptide (anti-CGRP)
2

Brand

Ajovy
6

Development codes

TEV-48125
10

Studies by the year they started

27 studies that test it; most in 2017 (8); 2 more planned to start later

Studies that test fremanezumab, by start year
YearStudies
20131
20142
20163
20178
20192
20205
20213
20222
20241

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
8
Phase 3
14
Phase 4
6
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 23 · Other 6

Teva Branded Pharmaceutical Products R&D, Inc. (17) · Otsuka Pharmaceutical Co., Ltd. (3) · Brigham and Women's Hospital (1) · Teva Branded Pharmaceutical Products R&D LLC (1) · David True (1) · M.D. Anderson Cancer Center (1) · Insel Gruppe AG, University Hospital Bern (1) · Beth Israel Deaconess Medical Center (1)

Often tested with

Tested in the same studies.

Prednisone (1) · Eptinezumab (1) · Erenumab (1) · Onabotulinum toxin A (1) · Botulinum toxin type A (1) · Galcanezumab (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test fremanezumab.

Studies

Open first, then newest update. How each study uses fremanezumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 29

See all 29 studies that test fremanezumab →

Codes

What other systems call fremanezumab · ClinicalTrials.gg INT000387

  • UNII (FDA) PF8K38CG54FREMANEZUMABConfirmed FDA, Wikidata
  • RxNorm 2056691Confirmed FDA, Wikidata
  • Wikidata Q39048381fremanezumabConfirmed FDA, Wikidata
  • NCI Thesaurus C174842FremanezumabOne source FDA
  • DrugBank DB14041One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.